Article

Lysophosphatidylcholines are associated with P-tau181 levels in early stages of Alzheimer’s Disease

2023-08-25

Abstract excerpt

<h4>Background</h4> We investigated systemic biochemical changes in Alzheimer’s disease (AD) by investigating the relationship between circulating plasma metabolites and both clinical and biomarker-assisted diagnosis of AD. <h4>Methods</h4> We used an untargeted approach with liquid chromatography coupled to high-resolution mass spectrometry to measure exogenous and endogenous small molecule metabolites in plasm...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 925e895d-b4d6-512f-b37f-80da84934c17
DOI: 10.1101/2023.08.24.23294581

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Lysophosphatidylcholines are associated with P-tau181 levels in early stages of Alzheimer’s DiseaseDOI 10.1101/2023.08.24.23294581Read

Lysophosphatidylcholines are associated with P-tau181 levels in early stages of Alzheimer’s DiseaseSemantic proximity Read

Differences in Plasma Metabolites Related to Alzheimer’s Disease, APOE-ε4 status and EthnicitySemantic proximity Read

CSF metabolites associated with biomarkers of Alzheimer’s disease pathologySemantic proximity Read

Sets of Co-regulated Serum Lipids are Associated with Alzheimer Disease PathophysiologySemantic proximity Read

CSF metabolites associated with biomarkers of Alzheimer’s disease pathologySemantic proximity Read

Integration of proteomics and metabolomics – insights into inflammation, metabolic dysregulation, and vascular aspects in ADSemantic proximity Read

Metabolomics in early Alzheimer's disease: identification of altered plasma sphingolipidome using shotgun lipidomics.Semantic proximity Read

Alzheimer's disease polygenic risk's association with all-cause dementia through the plasma metabolome in the UK Biobank study.Semantic proximity Read

Multiomics analysis to explore blood metabolite biomarkers in an Alzheimer’s Disease Neuroimaging Initiative cohortSemantic proximity Read

Metabolomic and lipidomic signatures in autosomal dominant and late-onset Alzheimer's disease brains.Semantic proximity Read

Biomarker-informed CSF proteomics reveals ENPP2–LPA lipid signaling associated with Alzheimer’s diseaseSemantic proximity Read

Genetic Regulation of the Metabolome Differs by Sex, Alzheimer’s Disease Stage, and Plasma Biomarker StatusSemantic proximity Read